A novel pyrazole derivative as COVID-19 main protease inhibitor: Synthesis, quantum computational studies, pharmacokinetic properties, drug likeness, molecular docking and dynamics simulation; a CADD approach
Chemical Physics Impact · 2024-06 · 8 · 100475
DOI: 10.1016/j.chphi.2024.100475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Physics Impact, 2024-06. Verfasst von D. Rekharani und 5 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rekharani, D., Shivalingegowda, N., Mahesha, Urs, M. D., Chethan, B., & Krishnappagowda, L. N. (2024). A novel pyrazole derivative as COVID-19 main protease inhibitor: Synthesis, quantum computational studies, pharmacokinetic properties, drug likeness, molecular docking and dynamics simulation; a CADD approach. Chemical Physics Impact, 8, 100475. https://doi.org/10.1016/j.chphi.2024.100475
Vancouver
Rekharani D, Shivalingegowda N, Mahesha, Urs MD, Chethan B, Krishnappagowda LN. A novel pyrazole derivative as COVID-19 main protease inhibitor: Synthesis, quantum computational studies, pharmacokinetic properties, drug likeness, molecular docking and dynamics simulation; a CADD approach. Chemical Physics Impact. 2024;8:100475. doi:10.1016/j.chphi.2024.100475
BibTeX
@article{Rekharani2024,
author = {Rekharani, D. and Shivalingegowda, Naveen and Mahesha and Urs, M.V. Deepa and Chethan, B.S. and Krishnappagowda, Lokanath Neratur},
title = {A novel pyrazole derivative as COVID-19 main protease inhibitor: Synthesis, quantum computational studies, pharmacokinetic properties, drug likeness, molecular docking and dynamics simulation; a CADD approach},
journal = {Chemical Physics Impact},
year = {2024},
volume = {8},
pages = {100475},
doi = {10.1016/j.chphi.2024.100475}
}
EUVIMED